ArticleMacromolecular bioscience2026
Biotechnological Control of Hydrogel Properties via Recombinant Protein Molecular Weight Engineering.
Article in Macromolecular bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biotechnological Control of Hydrogel Properties via Recombinant Protein Molecular Weight Engineering.Macromolecular bioscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Hydrogels based on natural polymers are widely used in 3D cell culture and tissue engineering due to their biocompatibility and tunability. In this work, recombinant collagen-derived proteins of defined molecular weights were designed and tested as precursors for methacrylated, photocrosslinkable hydrogels. Proteins of 25.6 kDa, 58 kDa, and 89.2 kDa were recombinantly expressed in Komagataella phaffii, methacrylated, and photocrosslinked to form well-defined hydrogels. A Design of Experiments (DoE) strategy was employed to quantify the effects of degree of functionalization (DoF) and precursor molecular weight on hydrogel stiffness, deformability, and swelling. For the first time, it was reported that both the DoF and molecular weight of recombinant proteins used for hydrogel fabrication significantly influence hydrogel properties. The molecular weight effects were most pronounced at lower chain lengths. Predictive models generated from the DoE revealed non-linear and interactive contributions of both parameters, while mixed-material formulations suggested non-additive behavior beyond the fitted design space. Additionally, biocompatibility for all materials was shown by live-dead staining of cells seeded onto the crosslinked materials. The results demonstrate that recombinant protein chain length can be used as a powerful design parameter to modulate hydrogel mechanics. Such materials not only enable xeno-free cultivation but also provide a biotechnological route toward rationally engineered biomaterials for diverse applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.